CeCors Inc CEOS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CEOS is a good fit for your portfolio.
News
-
VETCOMM Opens New Headquarters: Poised for Enhanced Operations and Team Collaboration
-
VETCOMM's Subscription Sales Surge Past $786,000 in 2023; CEOS Prepares for a Record First Quarter in 2024
-
Award-Winning Journalist Rafer Weigel Appointed Chief Content Officer at VETCOMM, Elevating CeCors' Strategic Content Vision
-
VETCOMM’s New Conquer Brand No-Nicotine Pouches Seeks to Carve Out a Share of the Billion-Dollar Market
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.01–0.05
- Bid/Ask
- $0.02 / $0.02
- Market Cap
- $254,779.91
- Volume/Avg
- 452,149 / 493,986
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CeCors Inc along with its subsidiaries is engaged in the research and development, production, and commercialization of therapeutic and medicinal entheogenic, adaptogenic, and nootropic ingredients and formulations for its premium functional product lines which are developed by its mycology and botany experts. The company is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability, and targeted delivery of entheogen-based therapeutics.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- —
- Total Number of Employees
- 6
- Website
- https://www.psykeyworld.com
Valuation
Metric
|
CEOS
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
CEOS
|
---|---|
Quick Ratio | 0.17 |
Current Ratio | 0.33 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
Metric
|
CEOS
|
---|---|
Return on Assets (Normalized) | −330.44% |
Return on Equity (Normalized) | −1,247.35% |
Return on Invested Capital (Normalized) | −521.60% |
Return on Assets
No chart available
Medical Instruments & Supplies Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Ybmckymdz | Chc | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Mkrgcmljn | Fpmvtr | $67.6 Bil | |
ALC
| Alcon Inc | Wxgnykp | Kwqth | $39.1 Bil | |
WST
| West Pharmaceutical Services Inc | Bffjbdpqn | Lrxk | $28.6 Bil | |
CLPBY
| Coloplast A/S ADR | Ysyplmtqn | Smqx | $27.9 Bil | |
RMD
| ResMed Inc | Ttryhwchgw | Pynmyb | $27.0 Bil | |
BAX
| Baxter International Inc | Hnxdqkyc | Dhdcmr | $20.9 Bil | |
COO
| The Cooper Companies Inc | Xpghmryt | Fbpdt | $17.9 Bil | |
HOLX
| Hologic Inc | Phcfgjph | Pbfwtc | $17.8 Bil | |
TFX
| Teleflex Inc | Mxrkm | Nyjwy | $9.9 Bil |